Friday, May 23, 2008

BLOGSCAN - Guidelines for Aprotinin

On the GoozNews blog, anonymous blogger "PM" discussed a set of guidelines written last year on the prevention of operative bleeding. The guidelines endorsed aprotinin to reduce bleeding despite concerns raised in a 2006 New England Journal of Medicine article. Subsequently, several studies showing increased risks of mortality for patients receiving the drug, and it is now off the market. PM wondered whether these guidelines enthusiasm related to the financial ties that a majority of authors reported with Bayer, the company that made aprotinin?